Khaled Musallam/LinkedIn
Sep 8, 2026, 08:23
Khaled Musallam: A Masterclass on Thalassemia Care in the MENA Region
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“Looking forward to this virtual 2-day Masterclass: ‘The MENA Thalassemia Experience’ on 30-31 October 2026.
This masterclass is developed and organized in collaboration with the Thalassaemia International Federation (TIF) and Medscape Education Global.
The immersive 2-day masterclass is designed for both experienced physicians and physicians in training across the Middle East and North Africa (MENA) region.
Limited ‘seats’ available, apply now to secure your place!”
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination
-
Oct 23, 2026, 15:29José Antonio García Erce: Preoperative Anemia Emerges as a Modifiable Surgical Risk in New POWER Study
-
Oct 23, 2026, 15:13Reza Shojaei: Manufactured Red Blood Cells vs Blood Donation
-
Oct 23, 2026, 14:29Jean Jacques Kiladjian: International Scientific Exchange at IHCAMS in Tianjin
-
Oct 23, 2026, 14:11Aravind Palraj: The Prolonged aPTT Puzzle in SLE
-
Oct 23, 2026, 13:56Chokri Ben Lamine: The Evolving Treatment Landscape of Persistent and Chronic ITP